Banawa, Fronny M.
HRN: 24-58-92 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/21/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/21/2024
02/27/2024
IV
500 Mg
Q 8 Hours
Ame
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes